We thus conducted a meta-analysis and TSA for a comprehensive assessment regarding the genetic influence of the XPC rs2228000 in the risk of various types of cancer, including bladder cancer, lung cancer, gastric cancer, melanoma, esophageal cancer, breast cancer, pancreatic cancer, and colorectal cancer. This evidence concerns the gene XPC and urinary bladder carcinoma.